| Date |
Research Question / Title |
Unique ID |
Research Team |
|
May 9, 2022
|
Is there any association or links between COVID and interferonopathy or polymyositis?
|
EOC220502 ESR
|
EOC
|
|
April 6, 2022
|
Is there evidence that children under 18 should receive the booster to increase their immunity?
|
EOC220102v002 ESR
|
EOC
|
|
March 31, 2022
|
What is the efficacy of a 4th booster dose for COVID-19?
|
EOC220304 RR
|
EOC
|
|
March 31, 2022
|
What is the incidence and duration of long COVID cases?
|
EPM210601v2 RR
|
Epidemiology & Modelling
|
|
March 29, 2022
|
What is the efficacy of a 4th booster dose for COVID-19?
|
EOC220304 ESR
|
EOC
|
|
March 11, 2022
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602v2 ESR
|
Epidemiology & Modelling
|
|
March 10, 2022
|
What is the safety/efficacy of the Novavax COVID-19 vaccine?
|
EOC220302 RR
|
EOC
|
|
March 4, 2022
|
What is the safety/efficacy of the Novavax vaccine?
|
EOC220302 ESR
|
EOC
|
|
March 3, 2022
|
What is the incidence and duration of long COVID cases?
|
EPM210601v002 ESR
|
Epidemiology & Modelling
|
|
February 10, 2022
|
What are the latest health policy definitions of being fully vaccinated?
|
EOC220101 RR
|
EOC
|
|
February 4, 2022
|
Is there evidence that children under 18 should receive the booster to increase their immunity?
|
EOC220102 RR
|
EOC
|
|
February 4, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 RR
|
EOC
|
|
February 2, 2022
|
How useful is it to continue with daily symptom screening of HCW,
and what are the screening policies?
|
EOC220104 ESR
|
EOC
|
|
January 25, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 ESR
|
EOC
|
|
January 17, 2022
|
What are the latest health policy definitions of being fully vaccinated?
|
EOC220101 ESR
|
EOC
|
|
January 14, 2022
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v020 ESR
|
Infectious Disease
|
|
December 30, 2021
|
How are rapid antigen tests being used in different settings? What is the evidence on the impact of the use of rapid antigen tests on COVID-19 outbreak parameters?
|
EOC211203 ESR
|
EOC
|
|
December 26, 2021
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v019 RR
|
Infectious Disease
|
|
November 30, 2021
|
What are the risks associated with repeated exposure to Ethylene Oxide from ongoing use of the Abbott Panbio AG COVID-19 Nasal swabs?
|
EOC211126 RR
|
EOC
|
|
November 26, 2021
|
What are the risks associated with repeated exposure to Ethylene Oxide from ongoing use of the Abbott Panbio AG COVID-19 Nasal swabs?
|
EOC211126 ESR
|
EOC
|
